To test this hypothesis, we specifically looked at CSF levels of neurofilament light chain (NfL), total Tau (tTau), and pTau‐231 (pTau) in a cohort of symptomatic HD patients who performed a comprehensive neuropsychological assessment and 3 T MRI acquisition. This evidence concerns the gene MAPT and Huntington disease.